Ashfield offers a comprehensive range of well-established and market-leading services including sales teams, nurse educators, healthcare communications, pharmacovigilance, market access, meetings and event management, tele-sales solutions, medical information, market research, training and business intelligence.

Ashfield’s ambition is to continue to grow and expand its business internationally, keeping and sustaining the ethos and drive that distinguishes the company in every location where it exists, with a focus on developing market leading services to support the industry, healthcare professionals and patients at all stages of the product life-cycle.

Ashfield Commercial and Ashfield Clinical
Ashfield provides contract sales (Ashfield Commercial) and patient support services (Ashfield Clinical) in 18 countries. Ashfield Commercial delivers both field-based sales representatives and telesales solutions, focused on educating healthcare professionals on specific products and devices. Ashfield Clinical provides field-based and contact-centre-based clinical educators. Their role is to support healthcare professionals in educating patients on their disease or treatment protocols, helping to ensure that patients take their medications accurately and consistently in line with approved indications. These services have traditionally been contracted on a country by country basis. However, a trend has emerged among some clients of procuring services on a multi-country or regional basis to ensure consistency of implementation from a single provider. 

Ashfield Communications
Ashfield Communications is one of the largest global medical communications businesses, and is well placed to sustain growth. Its 22 agencies provide extensive medical and marketing multi-channel communication services to over 120 clients. Services include medical writing, publication planning, event management and digital strategy and content services. Clients include large pharma companies, entrepreneurial start-ups, biotech and device suppliers, and those specialising in orphan drugs for rare diseases. Ashfield Communications has continued to strengthen and develop its leading position and drive operational excellence.